Asian Scientist Newsroom

ABOUT

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Stories by Asian Scientist Newsroom


Singapore Universities Top In Asia: QS World Uni Rankings 2016/17

The National University of Singapore and Nanyang Technological University are also the only two Asian institutions in the top 20 of the rankings table.

These Countries Are At Greatest Risk Of Zika, Study Shows

India, China, the Philippines, Indonesia, Nigeria, Vietnam, Pakistan, and Bangladesh are expected to be at greatest risk of Zika virus transmission because of their limited health resources.

World’s Oldest Fossils Reveal Life On Earth As Early As 3.7 Billion Years Ago

The discovery of the world's oldest fossils reveals that diverse life forms thrived on Earth 3.7 billion years ago.

Hey, Diddle Diddle, More Cows Born Around The Full Moon?

There might be some truth to the popular belief that more births happen during a full moon—at least with cows.

Female Fiddler Crabs Want Safety Over Sex: Study

When female fiddler crabs leave males behind during mating season, they aren't just being picky—they are seeking shelter from predators, research shows.

Hong Kong Chemists Synthesize Promising Antibiotic Teixobactin

Scientists in Hong Kong have successfully synthesized teixobactin and ten analogs with promising properties.

7 Must-Read Stories In August 2016

From homosexual termites to self-driving cabs, these are the stories that grabbed your attention in August.

ASLAN, A*STAR To Develop Therapeutic Antibody Against RON Kinase

ASLAN Pharmaceuticals will license a therapeutic antibody from A*STAR that targets the macrophage-stimulating protein receptor, also known as Recepteur d’Origine Nantais kinase.

Takeda To Develop Zika Vaccine With $19.8m BARDA Funding

The US$19.8 million initial funding will cover the development of a Zika vaccine through to a Phase I clinical trial.